Study Summary
This is a phase I clinical study to evaluate the safety and tolerability of CAR-T in patients with CEA-positive advanced/metastatic solid tumors, and to obtain the maximum tolerated dose of CAR-T and phase II Recommended dose.
Want to learn more about this trial?
Request More InfoInterventions
CEA CAR-T cellsBIOLOGICAL
After lymphodepletion with Fludarabine and Cyclophosphamide,CAR T cells were transfused intravenically
CEA CAR-T cellsBIOLOGICAL
After lymphodepletion with Fludarabine and Cyclophosphamide,CAR T cells were injected intraperitoneally
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The First Affiliated Hospital of Nanchang University | Nanchang | Jiangxi | China |